FDA says Wholly Liquid’s supplement website claims make seven products unapproved new drugs and misbranded.
What happened
FDA reviewed the company’s website in November and December 2021 and its Facebook page. It found claims that SpiroLaze, BioLaze, LiquiLaurin, Vit-B12, DeStress, Omega Plus, and Ionized Silver treat or prevent diseases such as Lyme disease, infections, depression, cancer, and Alzheimer’s. FDA says this makes them unapproved new drugs and misbranded because they lack adequate directions for use.
What FDA found
The company’s website and Facebook claims show the products are intended to treat or prevent diseases, making them drugs.
FD&C Act section 201(g)(1)(B) [21 U.S.C. 321(g)(1)(B)]The products are unapproved new drugs because FDA has not approved them for these disease uses.
FD&C Act sections 201(p), 301(d), and 505(a) [21 U.S.C. 321(p), 331(d), 355(a)]The products are misbranded because they lack adequate directions for safe use by a layperson for these serious diseases.
FD&C Act section 502(f)(1) [21 U.S.C. 352(f)(1)]; 21 CFR 201.5Selling these misbranded products in interstate commerce violates the FD&C Act.
FD&C Act section 301(a) [21 U.S.C. 331(a)]
What FDA wants
FDA asks the company to notify it in writing within 15 working days of the steps taken to address the violations, including how it will prevent recurrence and related documentation. If it cannot finish, it must explain why and give a completion date.
Who should pay attention
- dietary supplement brands making disease claims
- retailers and online marketplaces selling supplement products
- consumers using Lyme or immune-support products
This is a summary. Read the original letter on fda.gov.